Ayutara ...

Investors & News

Supporting the future of precision radiopharmaceuticals through transparency and disciplined clinical growth.

12+
Partners
$250M
Funding
5
Trials
3
Assets

Our Strategic Vision

We responsibly scale radiopharmaceutical innovation through clinical execution and sustainable infrastructure.

Clinical First

Real-world physicians guide every program.

Global Access

Supply chain built for sustainable patient impact.

Pipeline

Forward momentum through carefully staged clinical development.

Pre-clinical
Discovery
Phase I
Safety
Phase II
Efficacy
Phase III
Reg.

News & Press

Clinical, financial, and partnership updates.

Jan 2025
Series C Round Secured

Funding to accelerate global clinical expansion.

Dec 2024
Phase II Fully Enrolled

10+ sites completed enrollment ahead of schedule.

Oct 2024
EU Manufacturing Expansion

New collaboration to scale production.

Investor Reports

Corporate OverviewPDF →
Annual ReportPDF →
Investor DeckPDF →

Connect With Investor Relations

Partnering to build the future of radiopharmaceutical care.